These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2996169)

  • 1. Enhancing effect of dietary supplementation with omega-3 fatty acids on plasma fibrinolysis in normal subjects.
    Barcelli U; Glas-Greenwalt P; Pollak VE
    Thromb Res; 1985 Aug; 39(3):307-12. PubMed ID: 2996169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marine omega-3 fatty acids and atherosclerosis.
    Becker RC; Corrao JM
    Ann Intern Med; 1988 Apr; 108(4):641. PubMed ID: 2450503
    [No Abstract]   [Full Text] [Related]  

  • 3. Reduction in plasminogen activator inhibitor-1 (PAI-1) with omega-3 polyunsaturated fatty acid (PUFA) intake.
    Mehta J; Lawson D; Saldeen TJ
    Am Heart J; 1988 Nov; 116(5 Pt 1):1201-6. PubMed ID: 3142242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dietary fish oil on platelet function and plasma lipids in hyperlipoproteinemic and normal subjects.
    Zucker ML; Bilyeu DS; Helmkamp GM; Harris WS; Dujovne CA
    Atherosclerosis; 1988 Sep; 73(1):13-22. PubMed ID: 3178928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dietary saturated and n-6 polyunsaturated fatty acids on the incorporation of long-chain n-3 polyunsaturated fatty acids into blood lipids.
    Dias CB; Wood LG; Garg ML
    Eur J Clin Nutr; 2016 Jul; 70(7):812-8. PubMed ID: 26757835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary supplementation with highly purified eicosapentaenoic acid and docosahexaenoic acid does not influence PAI-1 activity.
    Hansen J; Grimsgaard S; Nordoy A; Bonaa KH
    Thromb Res; 2000 Apr; 98(2):123-32. PubMed ID: 10713313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmatic factors of haemostasis remain essentially unchanged except for PAI activity during n-3 fatty acid intake in type I diabetes mellitus.
    Spannagl M; Drummer C; Fröschl H; von Schacky C; Landgraf-Leurs MM; Landgraf R; Schramm W
    Blood Coagul Fibrinolysis; 1991 Apr; 2(2):259-65. PubMed ID: 1832569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the effects of dietary n-3 fatty acids (Maxepa) on plasma lipids and lipoproteins in patients with hyperlipidaemia.
    Simons LA; Hickie JB; Balasubramaniam S
    Atherosclerosis; 1985 Jan; 54(1):75-88. PubMed ID: 3888229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of fish oil on lipids, coagulation and fibrinolysis in patients with angina pectoris.
    Schmidt EB; Kristensen SD; Dyerberg J
    Artery; 1988; 15(6):316-29. PubMed ID: 3178506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect on blood lipids and haemostasis of a supplement of cod-liver oil, rich in eicosapentaenoic and docosahexaenoic acids, in healthy young men.
    Sanders TA; Vickers M; Haines AP
    Clin Sci (Lond); 1981 Sep; 61(3):317-24. PubMed ID: 6266735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of the long-term use of a diet enriched with omega-3 polyunsaturated fatty acids on the fatty acid composition, fibrinolytic system indices and lipid spectrum of the blood in patients with ischemic heart disease].
    Pyzh MV; Gratsianskiĭ NA; Dobrovol'skiĭ AB
    Kardiologiia; 1993; 33(10):46-50, 5-6. PubMed ID: 8139173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of n-3 polyunsaturated fatty acids on lipids, platelet function, coagulation, fibrinolysis and monocyte chemotaxis in patients with hypertension.
    Schmidt EB; Nielsen LK; Pedersen JO; Kornerup HJ; Dyerberg J
    Clin Chim Acta; 1990 Jul; 189(1):25-32. PubMed ID: 2383918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. n-3 fatty acids of marine origin lower systolic blood pressure and triglycerides but raise LDL cholesterol compared with n-3 and n-6 fatty acids from plants.
    Kestin M; Clifton P; Belling GB; Nestel PJ
    Am J Clin Nutr; 1990 Jun; 51(6):1028-34. PubMed ID: 1971991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma fibrinolytic activity after ingestion of omega-3 fatty acids in human subjects.
    Takimoto G; Galang J; Lee GK; Bradlow BA
    Thromb Res; 1989 Jun; 54(6):573-82. PubMed ID: 2781508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Maxepa on serum lipids in hypercholesterolaemic subjects.
    Dart AM; Riemersma RA; Oliver MF
    Atherosclerosis; 1989 Dec; 80(2):119-24. PubMed ID: 2692571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response studies on the effect of n-3 polyunsaturated fatty acids on lipids and haemostasis.
    Schmidt EB; Varming K; Ernst E; Madsen P; Dyerberg J
    Thromb Haemost; 1990 Feb; 63(1):1-5. PubMed ID: 2339345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of n-3 fatty acids on lipids and haemostasis in patients with type IIa and type IV hyperlipidaemia.
    Schmidt EB; Ernst E; Varming K; Pedersen JO; Dyerberg J
    Thromb Haemost; 1989 Sep; 62(2):797-801. PubMed ID: 2814927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary fish oils increase serum lipids in insulin-dependent diabetics compared with healthy controls.
    Mori TA; Vandongen R; Masarei JR; Stanton KG; Dunbar D
    Metabolism; 1989 May; 38(5):404-9. PubMed ID: 2542722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha-Linolenic, eicosapentaenoic and docosahexaenoic acids affect lipid metabolism differently in rats.
    Ikeda I; Wakamatsu K; Inayoshi A; Imaizumi K; Sugano M; Yazawa K
    J Nutr; 1994 Oct; 124(10):1898-906. PubMed ID: 7931698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinolysis in health and disease: abnormal levels of plasminogen activator, plasminogen activator inhibitor, and protein C in thrombotic thrombocytopenic purpura.
    Glas-Greenwalt P; Hall JM; Panke TW; Kant KS; Allen CM; Pollak VE
    J Lab Clin Med; 1986 Nov; 108(5):415-22. PubMed ID: 2430036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.